Suppr超能文献

经皮射频消融治疗肝细胞癌后的预后因素。不完全消融对复发率和总生存率的影响。

Prognostic Factors after Percutaneous Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma. Impact of Incomplete Ablation on Recurrence and Overall Survival Rates.

作者信息

Sparchez Zeno, Mocan Tudor, Radu Pompilia, Mocan Lavinia Patricia, Sparchez Mihaela, Leucuta Daniel Corneliu, Al Hajjar Nadim

机构信息

3rd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy;Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca , Romania.

Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca , Romania.

出版信息

J Gastrointestin Liver Dis. 2018 Dec;27(4):399-407. doi: 10.15403/jgld.2014.1121.274.pro.

Abstract

AIMS

To report on the long-term impact of tumor and non-tumor related parameters on local recurrence, distant recurrence and survival in patients with naïve or recurrent type hepatocellular carcinoma (HCC) treated by radiofrequency ablation (RFA).

METHODS

We performed 240 RFA sessions on 133 patients with 156 HCC nodules developed on a background of liver cirrhosis and analyzed the outcomes.

RESULTS

Contrast-enhanced ultrasound performed one month after RFA showed complete ablation in 119 out of 133 (89.65%) patients. With a median follow-up of 46 months, 3-, 5- and 7-year survival rates were 61.7%, 35.7%, and 22.6%, respectively. Previous ethanol injection and histological grade were significantly related to local tumor progression. Child-Pugh class, incomplete ablation, histological grade, previous ethanol injection, alpha-fetoprotein level before the treatment, and local recurrence were all significantly related to distant recurrence. Multivariate analysis demonstrated that age, Child-Pugh class, distant recurrence and multiple incomplete ablations were significantly related to survival.

CONCLUSION

Radiofrequency ablation could be locally curative for HCC, resulting in a survival longer than 7 years. Previous ethanol injection and incomplete ablations were strongly associated with poor outcomes.

摘要

目的

报告肿瘤及非肿瘤相关参数对接受射频消融(RFA)治疗的初发或复发型肝细胞癌(HCC)患者局部复发、远处复发及生存的长期影响。

方法

我们对133例肝硬化背景下出现156个HCC结节的患者进行了240次RFA治疗,并分析了治疗结果。

结果

RFA术后1个月行超声造影显示,133例患者中有119例(89.65%)达到完全消融。中位随访46个月,3年、5年和7年生存率分别为61.7%、35.7%和22.6%。既往乙醇注射及组织学分级与局部肿瘤进展显著相关。Child-Pugh分级、消融不完全、组织学分级、既往乙醇注射、治疗前甲胎蛋白水平及局部复发均与远处复发显著相关。多因素分析表明,年龄、Child-Pugh分级、远处复发及多次消融不完全与生存显著相关。

结论

射频消融对HCC可实现局部治愈,生存期超过7年。既往乙醇注射及消融不完全与不良预后密切相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验